NCT02203695: A trial that was reported late by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
This trial has reported, although it was 23 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02203695 |
|---|---|
| Title | Phase II Randomized Placebo-Controlled Double-Blind Study of Salvage Radiation Therapy (SRT) Plus Placebo Versus SRT Plus Enzalutamide in Men With High-Risk PSA-Recurrent Prostate Cancer After Radical Prostatectomy |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | March 28, 2015 |
| Completion date | Dec. 31, 2022 |
| Required reporting date | Dec. 31, 2023, midnight |
| Actual reporting date | Jan. 23, 2024 |
| Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
| Days late | 23 |